We are live on
!
Find out more
Ensign Peak Advisors Portfolio holdings
AUM
$53.7B
1-Year Est. Return
29.47%
This Fund
S&P 500
This Quarter
Est. Return
-2.36%
1 Year Est. Return
+29.47%
3 Year Est. Return
+102.45%
5 Year Est. Return
+139.11%
10 Year Est. Return
–
AUM
$46.8B
AUM Growth
-$2.48B
(-5%)
Cap. Flow
-$831M
Cap. Flow
% of AUM
-1.77%
Top 10 Holdings %
Top 10 Hldgs %
28.11%
Holding
1,786
New
25
Increased
394
Reduced
504
Closed
30
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Crown Castle
CCI
|
+$130M |
| 2 |
Amgen
AMGN
|
+$96.1M |
| 3 |
Progressive
PGR
|
+$94.9M |
| 4 |
AbbVie
ABBV
|
+$77.1M |
| 5 |
Kenvue
KVUE
|
+$75.6M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Eli Lilly
LLY
|
+$148M |
| 2 |
Johnson & Johnson
JNJ
|
+$147M |
| 3 |
LyondellBasell Industries
LYB
|
+$108M |
| 4 |
Dollar General
DG
|
+$91.2M |
| 5 |
ExxonMobil
XOM
|
+$87.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 24.48% |
| 2 | Healthcare | 17.42% |
| 3 | Financials | 12.53% |
| 4 | Consumer Discretionary | 9.71% |
| 5 | Communication Services | 7.51% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
251
VeriSign
VRSN
$25.5B
| $24.1M | 0.05% |
118,835
-2,359
| -2% | -$490K |
|
252
Sarepta Therapeutics
SRPT
$1.6B
| $24M | 0.05% |
197,645
-480
| -0.2% | -$54.3K |
|
253
CBRE Group
CBRE
$43.3B
| $23.9M | 0.05% |
324,210
-9,519
| -3% | -$789K |
|
|
KRTX
254
DELISTED
Karuna Therapeutics, Inc. Common Stock
KRTX
| $23.9M | 0.05% |
141,338
-35,726
| -20% | -$6.72M |
|
255
United Rentals
URI
$70.7B
| $23.7M | 0.05% |
53,330
+11,063
| +26% | +$5.06M |
|
256
AvalonBay Communities
AVB
$27.2B
| $23.6M | 0.05% |
137,285
-7,079
| -5% | -$1.31M |
|
257
Ferguson
FERG
$45B
| $23.4M | 0.05% |
142,462
+13,187
| +10% | +$2.08M |
|
258
Graco
GGG
$13.5B
| $23.3M | 0.05% |
319,592
+5,819
| +2% | +$460K |
|
259
Dorman Products
DORM
$4.18B
| $23.1M | 0.05% |
304,332
-96
| -0% | -$7.81K |
|
260
Corebridge Financial
CRBG
$14.4B
| $22.2M | 0.05% |
1,123,752
-47,088
| -4% | -$876K |
|
261
Casella Waste Systems
CWST
$5.75B
| $22.1M | 0.05% |
289,747
-2,946
| -1% | -$241K |
|
262
Idexx Laboratories
IDXX
$45.6B
| $21.9M | 0.05% |
49,992
-7,441
| -13% | -$3.71M |
|
263
CrowdStrike
CRWD
$178B
| $21.8M | 0.05% |
521,468
+90,916
| +21% | +$3.53M |
|
264
Kimberly-Clark
KMB
$38B
| $21.8M | 0.05% |
180,537
-17,951
| -9% | -$2.32M |
|
265
Extra Space Storage
EXR
$32.1B
| $21.8M | 0.05% |
179,149
-38,572
| -18% | -$5.18M |
|
266
Globant
GLOB
$1.51B
| $21.8M | 0.05% |
110,056
-43
| -0% | -$8.05K |
|
267
Occidental Petroleum
OXY
$55B
| $21.7M | 0.05% |
334,431
-17,205
| -5% | -$1.08M |
|
268
Tyson Foods
TSN
$22B
| $21.6M | 0.05% |
427,232
-30,307
| -7% | -$1.61M |
|
269
Ingersoll Rand
IR
$34B
| $21.3M | 0.05% |
334,139
-28,314
| -8% | -$1.88M |
|
270
SLB Ltd
SLB
$76.6B
| $21M | 0.04% |
359,883
-968,509
| -73% | -$56.2M |
|
271
Paychex
PAYX
$42.4B
| $20.4M | 0.04% |
176,731
-9,761
| -5% | -$1.18M |
|
272
Lennar Class A
LEN
$21.3B
| $20.3M | 0.04% |
187,155
| – | – |
|
273
Diamondback Energy
FANG
$55.6B
| $20.3M | 0.04% |
130,996
-49,559
| -27% | -$7.31M |
|
274
Cloudflare
NET
$89.3B
| $19.8M | 0.04% |
314,094
-150,731
| -32% | -$9.65M |
|
275
TransDigm Group
TDG
$73.2B
| $19.6M | 0.04% |
23,196
+945
| +4% | +$829K |
|
Similar funds
SCP
Ensign Peak Advisors's Q3 2023 Portfolio in Review
As of Q3 2023, Ensign Peak Advisors held 1,786 positions worth $46.8B, down 5% from $49.3B the previous quarter. Its ten largest holdings account for 28% of the portfolio.
Trading was light in Q3 2023: portfolio turnover was 3.1%. Ensign Peak Advisors opened 25 new positions and exited 30, leaving the 1,786-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 24% of assets, down from 25% a quarter earlier, followed by Healthcare and Financials.
- Ensign Peak Advisors's largest Q3 2023 buy was Invesco QQQ Trust: 160,000 shares worth $57.3M.
- Ensign Peak Advisors added most to Crown Castle in Q3 2023, an estimated $130M increase.
- Ensign Peak Advisors's biggest Q3 2023 reduction was Eli Lilly, cutting an estimated $148M.
- Ensign Peak Advisors fully exited RB Global in Q3 2023, selling an estimated $26.5M.
- Ensign Peak Advisors's ten largest holdings make up 28% of its $46.8B portfolio in Q3 2023.
- Ensign Peak Advisors opened 25 new positions and closed 30 in Q3 2023.
- Ensign Peak Advisors's portfolio value fell 5% quarter-over-quarter to $46.8B.
Based on Ensign Peak Advisors's 13F filing for Q3 2023, filed 13 Nov 2023.